Xcopri is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Sk Life Science, Inc.. The primary component is Cenobamate.
| Product ID | 71699-200_0834bd13-0cac-4670-9ed4-d0d6fed1d4ad |
| NDC | 71699-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Xcopri |
| Generic Name | Cenobamate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-03-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212839 |
| Labeler Name | SK Life Science, Inc. |
| Substance Name | CENOBAMATE |
| Active Ingredient Strength | 200 mg/1 |
| DEA Schedule | CV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2020-03-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA212839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-03-12 |
| Ingredient | Strength |
|---|---|
| CENOBAMATE | 200 mg/1 |
| SPL SET ID: | 565c2126-57ae-4e29-b443-723bbe7e2072 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 71699-050 | Xcopri | cenobamate |
| 71699-100 | Xcopri | cenobamate |
| 71699-102 | Xcopri | cenobamate |
| 71699-103 | Xcopri | cenobamate |
| 71699-104 | Xcopri | cenobamate |
| 71699-150 | Xcopri | cenobamate |
| 71699-200 | Xcopri | Xcopri |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XCOPRI 88485671 not registered Live/Pending |
SK BIOPHARMACEUTICALS CO., LTD. 2019-06-24 |
![]() XCOPRI 88484180 not registered Live/Pending |
SK BIOPHARMACEUTICALS CO., LTD. 2019-06-21 |
![]() XCOPRI 87349251 5426093 Live/Registered |
SK Biopharmaceuticals Co., Ltd. 2017-02-24 |